| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Gemayel Georges is a Director at SUPERNUS PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Director | Sale+OE | 10,787 | $36.30 | $391,568.10 | -44.8% | +6.1% | +25.7% | |
| Nov 7, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Director | Sale+OE | 14,213 | $36.62 | $520,480.06 | -51.6% | +8.5% | +26.4% | |
| Sep 13, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Director | Sale+OE | 13,886 | $31.33 | $435,048.38 | -34.3% | +16.2% | +46.1% |